SMi are thrilled to announce the release of the highly anticipated brochure for 14th annual Controlled Release Delivery taking place on 3rd to 4th of April in London.
PixarBio is using patent pending formulations of FDA approved biomaterials and FDA approved non-opiate drugs to target key neurological areas to treat pain. Thanks to their team's expertise on over 60 products approved by the FDA to start human studies, we have unmatched experience in the drug delivery system space and a track record of successfully developing FDA approved products.
SMi are delighted to have Duncan Emerton from FirstWord present at the 7th Annual Biosimilars Europe when it returns to London on 29TH-30TH September 2016.
SMi Group add two new Q&A's to the cancer vaccines interview series with Abzena and Genentech in the run up to their keynote addresses at Cancer Vaccines 2016.
SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years' COPD conference in London on 19-20th October.
SMi Group reports: Boehringer Ingelheim, EMD Serono and Teva will be presenting at this year's Biosimilars North America meeting in New Jersey, USA on November 16 - 17.
SMi Group reports : SMi's 11th annual Cold Chain Distribution returns in London this December with speakers from MHRA, Teva, Finnair Cargo, and many more.
Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency.
SMi Group reports : SMi's 11th annual Cold Chain Distribution will provide further insights into emerging market challenges for cold chain distribution. This event will take place in London in December.
SMi Group's 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be running at Holiday Inn, Kensington Forum in London from 10-11 October 2016.
SMi Reports : The 8th annual COPD conference will be returning to London on 19 - 20 October 2016. Experts from Novartis, Chiesi, MedImmune, and Mylan will speak at this event.
SMi's 3rd annual Immunogenicity will be returning to Holiday Inn Kensington Forum, London, UK on 13-14 June 2016 to discuss hot industry topics such as integration of immunogenicity risk data to forecast clinical outcomes, personalized cancer vaccine development and much more.
SMi Group's 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.
Webinar on Risk-Based Monitoring (RBM) on 25th May 2016. This webinar will help you assess whether your organization is ready for RBM as well as discuss steps to take to implement RBM.
SMi Group reports (2016.05.10, San Diego, California, USA): FDA will provide the latest updates on Pre-Filled Syringes and Combination Products at Pre-Filled Syringes West Coast 2016.
Satisfied Users & 
Approved Press Releases
